Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
11 studies found for:    HUPERZINE A
Show Display Options
Rank Status Study
1 Unknown  Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia
Conditions: Schizophrenia;   Dementia
Intervention: Drug: Huperzine A
2 Unknown  Comparative Bioavailability Study of an Immediate Release and Controlled Release Oral Formulations of Huperzine A
Conditions: Healthy;   Bioavailability
Intervention: Drug: Huperzine A
3 Recruiting Effects of Huperzine A in Treatment of Moderate to Severe TBI
Condition: Traumatic Brain Injury
Interventions: Drug: Huperzine A;   Drug: Placebo
4 Completed Huperzine A in Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: Huperzine A
5 Unknown  Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Huperzine A;   Drug: huperzine A;   Drug: Placebo
6 Not yet recruiting Effects of Hearing Rehabilitative Interventions and Huperzine A on Presbycusis(Δ,kHz, dB,MMSE, AD)
Conditions: Presbycusis;   Tinnitus;   Cognitive Impairment
Interventions: Device: digital hearing aids,;   Drug: Huperzine A;   Other: digital hearing aids and Huperzine A;   Other: placebo
7 Completed Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Conditions: Cocaine Dependence;   Cocaine Addiction;   Cocaine Abuse;   Substance Abuse
Interventions: Drug: Placebo;   Drug: Rivastigmine 3 mg;   Drug: Huperzine A 0.4 mg;   Drug: Rivastigmine 6 mg;   Drug: Huperzine A 0.8 mg
8 Completed Huperzine for Cognitive and Functional Impairment in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: placebo;   Drug: huperzine 0.2 mg BID;   Drug: huperzine 0.4 mg BID;   Drug: huperzine 0.8 mg BID
9 Not yet recruiting Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
Conditions: Mild Cognitive Impairment;   Biomarker;   Diagnosis;   Treatment
Interventions: Drug: Huperzine A;   Drug: Placebo
10 Completed Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance
Condition: Biomarkers, Pharmacological
Interventions: Drug: Huperzine A;   Drug: Donepezil;   Drug: Galantamine;   Other: Placebo
11 Completed Single Photon Emission Computed Tomography (SPECT) Imaging Study of Professional American Football Players
Condition: Traumatic Brain Injury
Intervention: Dietary Supplement: Multivitamin Supplement intervention

Study has passed its completion date and status has not been verified in more than two years.